Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts

Molecular Carcinogenesis

Volumn 22, Issue 2, 1998, Pages 84-94

  Li, Hui ^a   Bauzon, Delbert E ^a   Xu, Xinyun ^a   Tschesche, Harald ^b   Cao, Jian ^c   Sang, QingXiang Amy ^a  

^a FLORIDA STATE UNIVERSITY   (United States)

^b BIELEFELD UNIVERSITY   (Germany)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

Antibody production; Gelatinase A; Invasion and metastasis; Matrilysin; Proteinase processing

Indexed keywords

CELL SURFACE PROTEIN; COLLAGENASE; CONCANAVALIN A; ENZYME PRECURSOR; GELATINASE A; MATRILYSIN; MEMBRANE ENZYME; RABBIT ANTISERUM; SYNTHETIC PEPTIDE;

ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CARCINOMA CELL; CELL INTERACTION; CELL MEMBRANE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVATION; ENZYME ANALYSIS; HUMAN; HUMAN CELL; LUNG FIBROBLAST; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; BREAST NEOPLASMS; CELL MEMBRANE; ENZYME ACTIVATION; ENZYME PRECURSORS; FIBROBLASTS; GELATINASES; HUMANS; ISOENZYMES; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; MOLECULAR SEQUENCE DATA; SOLUBILITY; TUMOR CELLS, CULTURED;

EID: 0031835786     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199806)22:2<84::AID-MC3>3.0.CO;2-K     Document Type: Article

References (48)

1. Matrisian LM. The matrix-degrading metalloproteinases. Bio Essays 14:455-463, 1992.
2. Birkedal-Hansen H, Moore WGI, Bodden MK, et al. Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 4:197-250, 1993.
3. Sang QA, Douglas DA. Computational sequence analysis of matrix metalloproteinases. J Protein Chem 15:137-160, 1996.
4. Douglas DA, Shi YE, Sang QA. Computational sequence analysis of the tissue inhibitor of metalloproteinase family. Minireview. J Protein Chem 16:237-255, 1997.
5. Stetler-Stevenson WG, Aznavoorian S, Liotta LA. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Ann Rev Cell Biol 9:541-573, 1993.
6. Monteagudo C, Merino MJ, San-Juan J, Liotta LA, Stetler-Stevenson WG. Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue. Am J Pathol 136:585-592, 1990.
7. Stetler-Stevenson WG. Progelatinase A activation during tumor cell invasion. Invasion Metastasis 14:259-268, 1994-1995.
8. Davies B, Miles DW, Happerfield LC, et al. Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 67:1126-1131, 1993.
9. Sato H, Takino T, Okada Y, et al. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370:61-65, 1994.
10. Kinoshita T, Sato H, Takino T, Itoh M, Akizawa T, Seiki M. Processing of a precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type 1 matrix metalloproteinase. Cancer Res 56:2535-2538, 1996.
11. Okada A, Bellocq J-P, Rouyer N, et al. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci USA 92:2730-2734, 1995.
12. Heppner KJ, Matrisian LM, Jensen RA, Rodgers WH. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol 149:273-282, 1996.
13. Yu M, Sato H, Seiki M, Thompson EW. Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells. Cancer Res 55:3272-3277, 1995.
14. Pei D, Weiss SJ. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J Biol Chem 271:9135-9140, 1996.
15. Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular, matrix macromolecules. J Biol Chem 272:2446-2451, 1997.
16. Knauper V, Will H, Lopez-Otin C, et al. Cellular mechanisms for human procollagenase-3 (MMP-13) activation - Evidence that MT1-MMP(MMP-14)and gelatinase A (MMP-2) are able to generate active enzyme. J Biol Chem 271:17124-17131, 1996.
17. Sato M, Seki M. Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis. J Biochem (Tokyo) 119:209-215, 1996.
18. Sang Q-X, Birkedal-Hansen H, Van Wart HE. Proteolytic and non-proteolytic activation of human neutrophil progelatinase. Biochim Biophys Acta 1251:99-108, 1995.
19. Sang QA, Bodden MK, Windsor LJ. Activation of human progelatinase A by collagenase and matrilysin and activation of procollagenase by matrilysin. J Protein Chem 15:243-253, 1996.
20. Crawford HC, Matrisian LM. Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion Metastasis 14:234-245, 1994-1995.
21. Nicolson GL. Cancer progression and growth: Relationship of paracrine and autocrine growth mechanisms to organ preference of metastasis. Exp Cell Res 204:171-180, 1993.
22. Azzam HS, Arand G, Lippman ME, Thompson EW. Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production. J Natl Cancer Inst 85:1758-1764, 1993.
23. Bordier C. Phase separation of integral membrane proteins in Triton X-114 solution. J Biol Chem 256:1604-1607, 1981.
24. Monsky WL, Lin C-Y, Aoyama A, et al. A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells. Cancer Res 54:5702-5710, 1994.
25. Puente XS, Pendas AM, Llano E, Velasco G, Lopez-Otin C. Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res 56:944-949, 1996.
26. Harlow E, Lane D. Antibodies - A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1988.
27. Smith DE, Fisher PA. Identification, developmental regulation, and response to heat shock of two antigenically related forms of a major nuclear envelope protein in Drosophila embryos: Application of an improved method for affinity purification of antibodies using polypeptides immobilized on nitrocellulose blots. J Cell Biol 99:20-28, 1984.
28. Stetler-Stevenson WG, Krutzsch HC, Wacher MP, Margulies IMK, Liotta LA. The activation of human type IV collagenase proenzyme - Sequence identification of the major conversion product following organomercurial activation. J Biol Chem 264:1353-1356, 1989.
29. Lichte A, Kolkenbrock H, Tschesche H. The recombinant catalytic domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) induces activation of progelatinase A and progelatinase A complexed with TIMP-2. FEBS Lett 397:277-282, 1996.
30. Zucker S, Conner C, DiMassmo BI, et al. Thrombin induces the activation of progelatinase A in vascular endothelial cells. Physiologic regulation of angiogenesis. J Biol Chem 270:23730-23738, 1995.
31. Cao J, Rehemtulla A, Bohou W, Zucker S. Membrane type matrix metalloproteinase 1 activates pro-gelatinase A without furin cleavage of the N-terminal domain. J Biol Chem 271:30174-30180, 1996.
32. Cao J, Sato H, Takino T, Seiki M. The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation. J Biol Chem 270:801-805, 1995.
33. Zucker S, Wieman JM, Lysik RM, et al. Enrichment of collagen and gelatin degrading activities in the plasma membranes of human cancer cells. Cancer Res 47:1608-1614, 1987.
34. Sang Q-X, Stetler-Stevenson WG, Liotta LA, Byers SW. Identification of type IV collagenase in testicular cell culture: Influence of peritubular-Sertoli cell interactions. Biol Reprod 43:956-964, 1990.
35. Sang Q-X, Thompson EW, Grant D, Stetler-Stevenson WG, Byers SW. Soluble laminin and arginine-glycine-aspartic acid containing peptides differentially regulate type IV collagenase messenger RNA activation, and localization in testicular cell culture. Biol Reprod 45:387-394, 1991.
36. Sang Q-X, Dym M, Byers SW. Secreted metalloproteinases in testicular cell culture. Biol Reprod 43:946-955, 1990.
37. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 215:403-410, 1990.
38. Altschul SF, Madden TL, Schaffer AA, et al. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res 25:3389-3402, 1997.
39. Knight CG, Willenbrock F, Murphy G. A novel coumarin-labeled peptide for sensitive continuous assays of the matrix metalloproteinases. FEBS Lett 296:263-266, 1992.
40. Imai K, Ohuchi E, Aoki T, et al. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. Cancer Res 56:2707-2710, 1996.
41. Lohi J, Lehti K, Westermarck J, Kahari V-M, Keski-Oja J. Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate. Eur J Biochem 239:239-247, 1996.
42. Will H, Atkinson SJ, Butler GS, Smith B, Murphy G. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation - Regulation byTIMP-2 and TIMP-3. J Biol Chem 271:17119-17123, 1996.
43. Strongin AY, Marmer BL, Grant GA, Goldberg GI. Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2. J Biol Chem 268:14033-14039, 1993.
44. Sato H, Takino T, Kinoshita T, et al. Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MTI-MMP). FEBS Lett 385:238-240, 1996.
45. Fridman R, Toth M, Pena D, Mobashery S. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res 55:2548-2555, 1995.
46. Polette M, Gilles C, Marchand V, Seiki M, Tournier JM, Birembaut P. Induction of membrane-type matrix metalloproteinase 1 (MT1-MMP) expression in human fibroblasts by breast adenocarcinoma cells. Clin Exp Metastasis 15:157-163, 1997.
47. Sato H, Kinoshita T, Takino T, Nokayama K, Seiki M. Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett 393:101-104, 1996.
48. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI. Mechanism of cell surface activation of 72-kDa type IV collagenase: Isolation of the activated form of the membrane metalloprotease. J Biol Chem 270:5331-5338, 1995.